Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Revenue - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Mereo BioPharma (MREO) Other Gross PP&E Adjustments (2022 - 2025)

Mereo BioPharma (MREO) has disclosed Other Gross PP&E Adjustments for 4 consecutive years, with -$9.5 million as the latest value for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments fell 7.02% to -$9.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$9.5 million through Dec 2025, down 7.02% year-over-year, with the annual reading at -$9.5 million for FY2025, 7.02% down from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was -$9.5 million at Mereo BioPharma, down from $843000.0 in the prior quarter.
  • The five-year high for Other Gross PP&E Adjustments was $843000.0 in Q3 2025, with the low at -$9.5 million in Q4 2025.
  • Average Other Gross PP&E Adjustments over 4 years is -$3.1 million, with a median of $158500.0 recorded in 2024.
  • The sharpest move saw Other Gross PP&E Adjustments dropped 17.32% in 2024, then skyrocketed 636.78% in 2025.
  • Over 4 years, Other Gross PP&E Adjustments stood at -$7.9 million in 2022, then increased by 4.78% to -$7.5 million in 2023, then dropped by 17.32% to -$8.8 million in 2024, then dropped by 7.02% to -$9.5 million in 2025.
  • According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at -$9.5 million, $843000.0, and $806000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.